Louie Ngar Yee - 30 Jun 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Louie Ngar Yee
Issuer symbol
MAIA
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 16:16:10 UTC
Previous filing
08 Apr 2025
Next filing
06 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Louie Ngar Yee Director 444 WEST LAKE STREET, SUITE 1700, CHICAGO /s/ Louie Ngar Yee 02 Jul 2025 0001913264

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +25,232 $0.000000 25,232 30 Jun 2025 Common Stock 25,232 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.